Atorvastatin Attenuates Bleomycin-Induced Pulmonary Fibrosis via Suppressing iNOS Expression and the CTGF (CCN2)/ERK Signaling Pathway
Zhu, B.; Ma, A.-Q.; Yang, L.; Dang, X.-M. Atorvastatin Attenuates Bleomycin-Induced Pulmonary Fibrosis via Suppressing iNOS Expression and the CTGF (CCN2)/ERK Signaling Pathway. Int. J. Mol. Sci. 2013, 14, 24476-24491. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms141224476
Zhu B, Ma A-Q, Yang L, Dang X-M. Atorvastatin Attenuates Bleomycin-Induced Pulmonary Fibrosis via Suppressing iNOS Expression and the CTGF (CCN2)/ERK Signaling Pathway. International Journal of Molecular Sciences. 2013; 14(12):24476-24491. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms141224476
Chicago/Turabian StyleZhu, Bo; Ma, Ai-Qun; Yang, Lan; Dang, Xiao-Min. 2013. "Atorvastatin Attenuates Bleomycin-Induced Pulmonary Fibrosis via Suppressing iNOS Expression and the CTGF (CCN2)/ERK Signaling Pathway" Int. J. Mol. Sci. 14, no. 12: 24476-24491. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms141224476